Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Someone reading a scientific publication on CT Radiomics, sarcopenia, gastric or esophageal cancer

CT-Radiomics unveils insights into sarcopenia's impact on esophageal and gastric cancer prognosis

Analyzing 83 patients with contrast-enhanced CT scans, University Hospital Ulm researchers tracked the prevalence of sarcopenia at different time points. They used mint Lesion™ for muscle segmentation and extraction of 85 radiomic features. These features, categorized into shape, first-order, and higher-order types, provided a detailed assessment of skeletal muscles. Machine learning models, including Random Forest, accurately predicted sarcopenia at the initial diagnosis.

While sarcopenia's link to disease progression lacked statistical significance, the study highlights CT radiomics and machine learning's potential in oncological imaging for refined diagnostics and prognostics.

Related Resources

Related Resources

Doctor looking at a CT scan in mint Lesion™

Software-Assisted CT Assessment Outperforms Manual Methods in Oncology Study

A recent study conducted at UKE Hamburg compared manual and software-assisted assessments of computed tomography (CT) scans according to iRECIST…

Diagram that shows reduced reading times for the mint Lesion™ approach at both follow-ups.

UKE Hamburg: Study Shows that Software-Assisted Assessments Enhance iRECIST Evaluation

This research study [1] aimed to compare the feasibility and reliability of manual versus software-assisted assessments of computed tomography (CT)…

mint Lesion screenshot with segmented muscles and radiomics

University Hospital Ulm: CT Radiomics and Machine Learning in Sarcopenia Evaluation for Esophageal and Gastric Cancer Patients

A recent study [1] conducted by researchers at University Hospital Ulm explored the role of sarcopenia in patients with esophageal or gastric cancer.…